StockNews.com assumed coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a research note issued to investors on Monday morning. The brokerage issued a sell rating on the stock.
Ayala Pharmaceuticals Stock Performance
NASDAQ ADXS opened at $0.02 on Monday. Ayala Pharmaceuticals has a 12 month low of $0.00 and a 12 month high of $1.49. The stock has a market cap of $852,600.00, a P/E ratio of 0.00 and a beta of 1.55. The stock’s fifty day moving average price is $0.21 and its 200-day moving average price is $0.49.
About Ayala Pharmaceuticals
Read More
- Five stocks we like better than Ayala Pharmaceuticals
- What is the Euro STOXX 50 Index?
- Joby Aviation Stock: The Case for Upside Just Got Stronger
- Golden Cross Stocks: Pattern, Examples and Charts
- Conviction Firms for Microsoft’s Double-Digit Stock Upside
- What is a Bond Market Holiday? How to Invest and Trade
- 5 Aggressive Growth Stocks for Long-Term Investors
Receive News & Ratings for Ayala Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ayala Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.